| |
|
|
|
|
|
|
GROUP |
|
COMPANY |
|
| |
|
|
|
|
Year ended |
|
Year ended |
|
Year ended |
|
Year ended |
|
| |
|
|
|
|
31 Dec 2005 |
|
31 Dec 2004 |
|
31 Dec 2005 |
|
31 Dec 2004 |
|
| |
|
|
|
|
|
|
Restated |
|
|
|
Restated |
|
| |
|
|
|
|
Rm |
|
Rm |
|
Rm |
|
Rm |
|
34.
|
CASH FLOW STATEMENT
|
|
|
|
|
|
|
|
|
|
|
| |
34.1
|
Cash generated from/(utilised by) operations
|
|
|
|
|
|
|
|
|
|
|
| |
|
Operating profit/(loss) before taxation and impairment of subsidiaries |
|
|
248,7 |
|
265,9 |
|
16,2 |
|
(15,2) |
|
| |
|
Adjusted for: |
|
|
|
|
|
|
|
|
|
|
| |
|
Depreciation |
|
|
42,2 |
|
23,3 |
|
0,3 |
|
|
|
| |
|
Impairment of investment property |
|
|
0,8 |
|
|
|
|
|
|
|
| |
|
Release of negative goodwill |
|
|
|
|
(134,7) |
|
|
|
|
|
| |
|
(Profit)/loss on disposal of property, plant and equipment |
|
|
(15,0) |
|
(2,2) |
|
|
|
0,2 |
|
| |
|
Profit on disposal of subsidiaries |
|
|
|
|
(3,1) |
|
|
|
|
|
| |
|
Decrease in retirement benefit obligation |
|
|
(20,8) |
|
(1,9) |
|
|
|
(0,4) |
|
| |
|
Increase in fair value of biological assets |
|
|
(6,1) |
|
(3,8) |
|
|
|
|
|
| |
|
Unrealised gain on listed investment |
|
|
(0,5) |
|
|
|
|
|
|
|
| |
|
Foreign exchange differences |
|
|
|
|
0,1 |
|
|
|
|
|
| |
|
Reversal of negative provision for impairment of investment in subsidiaries on sale |
|
|
|
|
|
|
|
|
9,6 |
|
| |
|
Net finance cost/(income) |
|
|
19,4 |
|
10,6 |
|
(6,2) |
|
(7,7) |
|
| |
|
Dividends received |
|
|
|
|
|
|
(20,9) |
|
|
|
| |
|
Income from joint ventures |
|
|
(0,7) |
|
(1,2) |
|
|
|
|
|
| |
|
Pension fund surplus recognised |
|
|
(50,6) |
|
|
|
|
|
|
|
| |
|
Share-based payment reserve movement |
|
|
1,1 |
|
11,8 |
|
1,1 |
|
11,8 |
|
| |
|
Operating profit/(loss) before changes in working capital |
|
|
218,5 |
|
164,8 |
|
(9,5) |
|
(1,7) |
|
| |
|
Movements in working capital: |
|
|
|
|
|
|
|
|
|
|
| |
|
Increase in inventory and biological assets |
|
|
(79,9) |
|
(36,7) |
|
|
|
|
|
| |
|
(Increase)/decrease in accounts receivable |
|
|
(29,5) |
|
12,0 |
|
(0,8) |
|
0,1 |
|
| |
|
Increase (decrease) in accounts payable and provisions |
|
|
23,9 |
|
(19,7) |
|
1,8 |
|
(1,5) |
|
| |
|
Cash generated from/(utilised by) operations |
|
|
133,0 |
|
120,4 |
|
(8,5) |
|
(3,1) |
|
| |
34.2
|
Taxation paid is reconciled as follows:
|
|
|
|
|
|
|
|
|
|
|
| |
|
Amounts unpaid at the beginning of the year |
|
|
(1,6) |
|
(5,3) |
|
(4,4) |
|
(4,5) |
|
| |
|
Subsidiaries acquired |
|
|
|
|
(6,9) |
|
|
|
|
|
| |
|
Disposal of subsidiaries |
|
|
|
|
0,1 |
|
|
|
|
|
| |
|
(Charged)/credited to the income statement |
|
|
(6,8) |
|
(3,0) |
|
2,9 |
|
(1,8) |
|
| |
|
Amounts unpaid at the end of the year |
|
|
5,3 |
|
1,6 |
|
1,3 |
|
4,4 |
|
| |
|
Taxation paid |
|
|
(3,1) |
|
(13,5) |
|
(0,2) |
|
(1,9) |
|
| |
| |
|
|
|
|
GROUP |
|
| |
|
|
|
|
Year ended |
|
Year ended |
|
| |
|
|
|
|
31 Dec 2005 |
|
31 Dec 2004 |
|
| |
|
|
|
|
Rm |
|
Rm |
|
| |
34.3
|
Acquisition of subsidiaries
|
|
|
|
|
|
|
| |
|
Particulars of net assets acquired at date of acquisition: |
|
|
|
|
|
|
| |
|
Property, plant and equipment |
|
|
1,0 |
|
278,6 |
|
| |
|
Investment property |
|
|
|
|
5,8 |
|
| |
|
Investments in joint ventures |
|
|
|
|
10,8 |
|
| |
|
Receivables and loans |
|
|
|
|
26,8 |
|
| |
|
Inventory |
|
|
3,0 |
|
259,0 |
|
| |
|
Accounts receivable |
|
|
2,5 |
|
387,2 |
|
| |
|
Deferred taxation assets |
|
|
|
|
147,2 |
|
| |
|
Short-term loans receivable |
|
|
|
|
3,4 |
|
| |
|
SARS income tax
receivable |
|
|
|
|
0,2 |
|
| |
|
Cash and cash equivalents |
|
|
|
|
30,1 |
|
| |
|
Minorities |
|
|
|
|
(7,1) |
|
| |
|
Interestbearing
borrowings |
|
|
(1,3) |
|
(134,5) |
|
| |
|
Interestfree
borrowings |
|
|
|
|
(6,1) |
|
| |
|
Deferred taxation liabilities |
|
|
|
|
(0,2) |
|
| |
|
Retirement benefit obligations |
|
|
|
|
(32,7) |
|
| |
|
Accounts payable |
|
|
(5,2) |
|
(307,8) |
|
| |
|
Provisions |
|
|
|
|
(23,3) |
|
| |
|
SARS income tax
payable |
|
|
|
|
(7,2) |
|
| |
|
Short-term borrowings |
|
|
|
|
(21,2) |
|
| |
|
Bank overdraft |
|
|
|
|
(95,8) |
|
| |
|
Net assets acquired |
|
|
|
|
513,2 |
|
| |
|
Negative goodwill |
|
|
|
|
(134,7) |
|
| |
|
Purchase consideration |
|
|
|
|
378,5 |
|
| |
|
Bank overdrafts acquired |
|
|
|
|
65,7 |
|
| |
|
Subsidiaries acquired, net of bank overdrafts acquired |
|
|
|
|
444,2 |
|
|
On 1 January 2005 the group acquired the entire share capital of Inyathi UK Limited , a company in the footwear industry, for a purchase consideration of R1. The acquisition was accounted for by the purchase method of accounting. |
|
The subsidiaries acquired on 1 July 2004 were as follows (all 100% unless otherwise indicated): |
| |
Calan Limited, Calan Retread Services (Proprietary) Limited, Carlo de Firenze (Proprietary) Limited, Casa Rosada Investments (Proprietary) Limited, Centeon Pharma (Proprietary) Limited, Chemical Leasing (Proprietary) Limited, Chemical Plant Finance (Proprietary) Limited, Conshu Holdings Limited, Conshu Limited, Conshu Trading (Proprietary) Limited, Dano Textile Industries (Proprietary) Limited, Danoduv Investments (Proprietary) Limited, Durban Fibres (Proprietary) Limited, Feltex Fehrer (Proprietary) Limited (74%), Feltex Limited, Hosaf Fibres (Proprietary) Limited, Jordan Footwear Namibia (Proprietary) Limited, Lanatex Weaving Manufacturers (Proprietary) Limited, Marker Investments (Proprietary) Limited, Persaltum (Proprietary) Limited and Textowel Weavers (Proprietary) Limited. All the above acquisitions were accounted for by the purchase method of accounting. |
| |
| |
|
|
|
|
GROUP |
|
| |
|
|
|
|
Year ended |
|
Year ended |
|
| |
|
|
|
|
31 Dec 2005 |
|
31 Dec 2004 |
|
| |
|
|
|
|
Rm |
|
Rm |
|
| |
|
The purchase consideration comprises the following: |
|
|
|
|
|
|
| |
|
Cost of acquisition (issuance of shares) |
|
|
|
|
375,9 |
|
| |
|
Costs directly relating to acquisition |
|
|
|
|
2,6 |
|
| |
|
Purchase consideration |
|
|
|
|
378,5 |
|
| |
| |
|
|
|
|
GROUP |
|
| |
|
|
|
|
Year ended |
|
Year ended |
|
| |
|
|
|
|
31 Dec 2005 |
|
31 Dec 2004 |
|
| |
|
|
|
|
Rm |
|
Rm |
|
| |
34.4
|
Disposal of subsidiaries
|
|
|
|
|
|
|
| |
|
Particulars of net assets sold at date of sale: |
|
|
|
|
|
|
| |
|
Property, plant and equipment |
|
|
|
|
0,5 |
|
| |
|
Investments and loans |
|
|
|
|
|
|
| |
|
Inventory |
|
|
|
|
1,4 |
|
| |
|
Accounts receivable |
|
|
|
|
0,5 |
|
| |
|
Cash and cash equivalents |
|
|
|
|
|
|
| |
|
Bank overdraft |
|
|
|
|
(0,2) |
|
| |
|
Long-term liabilities |
|
|
|
|
|
|
| |
|
Accounts payable |
|
|
|
|
(3,1) |
|
| |
|
SARS income tax payable |
|
|
|
|
(0,1) |
|
| |
|
Net liabilities sold |
|
|
|
|
(1,0) |
|
| |
|
Profit on disposal |
|
|
|
|
3,1 |
|
| |
|
Sale consideration |
|
|
|
|
2,1 |
|
| |
|
Cash sold |
|
|
|
|
0,2 |
|
| |
|
Proceeds on disposal of subsidiaries |
|
|
|
|
2,3 |
|
|
|
The subsidiaries sold on 1 January 2004 were are as follows (all 100%):
|
|
|
Exotan (Proprietary) Limited, Matsapa Hides & Stores (Proprietary) Limited, Border Export (Proprietary) Limited, Bregin & Co (Cape) (Proprietary) Limited, Cape Produce Export Co (Proprietary) Limited, South West Wool Sorters (Proprietary) Limited, OSB Exports (Proprietary) Limited, Kaftan NV, Manzini Hide Collectors (Proprietary) Limited, S M Lurie and Company (Botswana) (Proprietary) Limited, GH Hackmann (Proprietary) Limited, Hideskin Namibia (Proprietary) Limited, African Hide Trading Namibia (Proprietary) Limited, Oudtshoorn Ostrich Processors (Proprietary) Limited, Kolosus Leathers Africa, Barvan Pvt and Velskin Product (Proprietary) Limited. |